Abstract Ghrelin is a peptide hormone predominantly produced in the stomach. Ghrelin expression has also been reported in other tissues including the pancreas. We have reported that ghrelin cells constitute a novel endocrine cell type in the human and the developing rat islets. The cells are most numerous pre-and neonatally and, in humans, constitute 10% of all islet cells from mid-gestation to birth. Since gastric ghrelin expression is low before birth, the islets may be the main source of circulating ghrelin during this time. In the present investigation, we have performed an ultrastructural analysis of pancreatic ghrelin cells in human fetuses by using transmission electron microscopy and immunogold labelling. In addition, morphometrical analysis of secretory granules size was performed. Our data provide evidence for the unique ultrastructural features of ghrelin cells versus other islet cells. Notably, the secretory granules of ghrelin cells were of small size with a mean dense-core diameter of 110 nm. We conclude that ghrelin cells constitute a novel islet cell type, distinct from the previously hormonally characterised islet cell types.
Introduction
Ghrelin is a novel hormone with multiple documented effects, including metabolic regulation (Kojima et al. 1999;  for a review, see Korbonits et al. 2004 ). Although ghrelin is predominantly a gastric hormone, expression has been reported in a number of tissues including the pancreas (Date et al. 2002; Volante et al. 2002; Wierup et al. 2002; ; for a review, see Korbonits et al. 2004) . We have recently reported that ghrelin cells constitute a novel endocrine cell type in pancreatic islets in human (Wierup et al. 2002) and rat ; in human pancreas, the ghrelin cells are devoid of any of the "classical" islet hormones. The pancreatic ghrelin cells display a characteristic developmental regulation and constitute 10% of all islet cells from mid-gestation to birth. In islets of adults, the cells are much fewer and constitute about 1% of all islet cells (Wierup et al. 2002) . The development profile of ghrelin immunoreactivity in human pancreas has in part been confirmed by others (Rindi et al. 2002) . In rats, pancreatic ghrelin cells are present from embryonic day 15 to 1 month postnatally and a minor subpopulation of the ghrelin cells co-express glucagon or pancreatic polypeptide (PP) during a short period around birth . These data were controversial since two groups have presented data indicating ghrelin expression in glucagon cells (Date et al. 2002) or insulin cells (Volante et al. 2002) . However, recent studies of developing mice support our finding of an independent islet ghrelin cell (Prado et al. 2004 ). We and others have reported that, perinatally, gastric ghrelin cells are few (Björkqvist et al. 2002; Wierup et al. 2002; ) and others have reported that ghrelin gene expression in the fetal rat pancreas is higher than in the stomach (Chanoine and Wong 2004) . Hence, the pancreas may be the main site of ghrelin production during development.
The ultrastructural identification of the gastric ghrelin cells in rodents has been facilitated by early detailed electron-microscopic studies of gastric endocrine cells (for references, see Sundler and Håkanson 1988) . Thus, in rat and mouse, it has become evident that A-like cells are equivalent to ghrelin cells (Dornonville de la Cour et al. 2001) . Further, the ultrastructure of human gastric ghrelin cells has been investigated recently by using immunogold tech-nique; the cells are characterised by small round compact to thin-haloed secretory granules (Rindi et al. 2002) . Hitherto, there has been no information concerning the ultrastructure of pancreatic ghrelin cells. Islet cells with small secretory granules have been reported but not yet characterised with respect to hormone content (Sundler and Håkanson 1988) . Such cells include the P-cell and the D1-cell (Capella et al. 1978; Larsson et al. 1976; Solcia et al. 1987) . The distinction between these two cell types is unclear and cells with small granules have often been collectively classified as P/D1 cells (Bordi et al. 1986; Sundler and Håkanson 1988) . To increase our knowledge about the cellular origin of pancreatic ghrelin in man, we have examined ghrelin cells in human fetal pancreas by using transmission electron microscopy (TEM) and immunogold labelling.
Materials and methods

Tissue
Since the ghrelin cell density is ten times higher in fetal pancreas compared with adult pancreas (Wierup et al. 2002) , sampling of ghrelin cell profiles was facilitated by limiting our study to fetal pancreas. Pancreatic specimens from three human fetuses (gestational age: 21-22 weeks) were from legal abortions and collected during the 1970s according to the contemporary ethical guidelines.
Electron microscopy and immunogold
Specimens were fixed overnight in 0.075 M Sörensen buffer containing 3% parafomaldehyde and 1% glutaraldehyde, rinsed in Sörensen buffer, post-fixed for 1 h with 1% OsO 4 in the same buffer, dehydrated in acetone and embedded in Epon. Alternatively, specimens were embedded without post-fixation in OsO 4 for immunogold. Ultrathin sections were cut and placed on copper grids or on gold grids for immunogold labelling. For immunogold, sections were blocked with phosphate-buffered saline (PBS), pH 7.2, containing 0.5% bovine serum albumin (BSA), incubated overnight at 4°C with primary antisera (ghrelin, code H-031-31, dilution 1:100, Phoenix, Belmont, Calif., USA; glucagon, code 8711, dilution 1:2,560, EuroDiagnostica, Malmö, Sweden; insulin, code 9003, dilution 1:100, EuroDiagnostica), diluted in PBS containing 0.25% BSA and 0.25% Triton X-100, washed thoroughly in PBS and thereafter incubated for 1 h at room temperature with protein A-gold solution (10 nm diameter, dilution 1:20, Amersham-Pharmacia Biotech, Uppsala, Sweden) and again washed in PBS (Böttcher et al. 1986 ). All grids were contrasted with 0.5% lead citrate and 4% uranyl acetate before examination in a Philips CM10 transmission electron microscope.
TEM identification of immunoreactive cells
This method has been described previously (Larsson et al. 1976 ). Semi-thin sections (1 μm thickness) were cut and mounted on slides for immunocytochemistry (ICC). The immediately adjacent ultra-thin sections (50-70 nm thickness) were then processed for TEM as above. The semithin sections were deplasticized with KOH and ethanol and used for indirect immunofluorescence. Briefly, the sections were incubated with two primary antibodies simultaneously (rabbit anti-ghrelin, code H-031-31, dilution 1:3,200, Phoenix; guinea-pig anti-glucagon, code 8708, dilution 1:5,120, EuroDiagnostica; guinea-pig anti-insulin, code 9003, dilution 1:2,560, EuroDiagnostica) diluted in the same buffer as above, overnight at 4°C, followed by rinses in PBS with Triton X-100 for 2×10 min. Thereafter, two different secondary antibodies with specificity for rabbit-IgG or guinea-pig-IgG and coupled to either fluorescein isothiocyanate (FITC), dilution 1:100 (Jackson, West Grove, Pa., USA), or Texas-Red, dilution 1:400 (Jackson), were applied to the sections. Incubation was carried out for 1 h at room temperature. Sections were again rinsed in Triton X-100-enriched PBS for 2×10 min and then mounted in PBS:glycerol (1:1). The specificity of immunostaining was tested by using primary antisera pre-absorbed with homologus antigen (100 μg synthetic peptide per ml antiserum at the working dilution) or by omission of the primary antibodies. In addition, ghrelin antibodies were pre-absorbed with glucagon and insulin as above. The immunostained semi-thin sections were analysed in an epifluorescence microscope (Olympus DP50) and images of immunoreactive (IR) cells were taken with a digital camera (Olympus BX60). The images were then used as guides for the orientation and identification of IR cells in the adjacent ultrathin section using TEM.
Morphometry
Secretory granule diameter was measured on digitised images by using NIH-image software. The analysis comprised 460 granules from eight ghrelin cells and 430 granules from seven glucagon cells. Results are shown as means ± SEM. Data were analysed by Student's unpaired t-test. Differences with a value of P<0.05 were considered significant.
Results
Detection of ghrelin cells and morphometry
To locate ghrelin cells, semi-thin sections double-immunostained for ghrelin and glucagon or ghrelin and insulin (glucagon and insulin were also used as islet markers) were analysed by epi-fluorescence microscopy and images of IR cells were captured with a digital camera. With the image as a guide, ghrelin-IR and glucagon-IR cells were localised in ultrathin sections by TEM (Fig. 1) . The ghrelin cells were located at the islet periphery or in the exocrine tissue, often in the vicinity of glucagon cells. Ghrelin-IR and insulin-IR cells were localised in the same way (not shown). Ghrelin immunoreactivity was always in cells distinct from glucagon-IR or insulin-IR cells. Ghrelin cell secretory granules were small, spherical, and displayed variable electron density, from dense to rather electronlucent (Fig. 1b) . Further, the limiting membrane appeared to be tightly applied to the dense core of most of the granules. Morphometrical analysis revealed that the ghrelin granules (dense core) had a mean diameter of 110±3 nm, ranging from 70 nm to 160 nm in individual cells. By comparison, glucagon cell granules were highly electron dense and larger, with a mean diameter of 185±7 nm, (P<0.001 versus ghrelin cell granules). Ghrelin cell granules were clearly different from those of insulin cells, as recognised by their characteristic irregular crystalline dense core. Ghrelin cell granules were also clearly different from those of somatostatin cells, characterised by the large dense core of low electron density and from those of PP-cells recognised by the irregularly shaped moderately electrondense granule core (Sundler and Håkanson 1988) . Granules of the various islet cell types are illustrated in Fig. 2 .
Immunogold labelling
The identity of ghrelin cells was further verified with immunogold labelling for ghrelin, glucagon and insulin. Within the cells, labelling for ghrelin was found predominantly on the secretory granules (Fig. 3a-c) . Ghrelin cells were devoid of labelling for insulin or glucagon. In addition, insulin cells, glucagon cells, somatostatin cells and PP-cells were devoid of labelling for ghrelin. The appearance of immunogold labelling for glucagon and insulin is illustrated in (Fig. 3d-i) . Weak scattered unspecific background labelling was seen with all three antibodies.
Discussion
The main islet cell types (insulin cells, glucagon cells, somatostatin cells and PP-cells) have previously been characterised, and each has a unique ultrastructural appearance (for a review, see Sundler and Håkanson 1988) . In the present study, we provide evidence that also ghrelin cells have unique ultrastructural features that distinguish them from the previously characterised endocrine islet cells. Conflicting reports have appeared concerning the cellular origin of pancreatic ghrelin. Thus, Date et al. (2002) presented results indicating that ghrelin is expressed in the glucagon cells of human and rat islets. Volante et al. (2002) , on the other hand, reported data indicating ghrelin expression in human insulin cells. There is no ready explanation for this discrepancy but our present data together with our previous findings Wierup et al. 2002; and recent findings by others (Prado et al. 2004) do not support the expression of ghrelin in glucagon cells or insulin cells. Rather, our present data further support that ghrelin cells constitute a separate islet cell population.
Ultrastructurally, ghrelin cells were easily distinguished from insulin cells, which are recognised by their characteristic irregular crystalline granules (for references, see Klöppel and Heitz 1984) . Further, ghrelin cells were clearly distinct from somatostatin cells and PP-cells, which are recognised by their large electron-lucent granules and small, irregularly shaped, moderately electron-dense granules, respectively, as previously described (Sundler and Håkanson 1988) . Furthermore, although clearly different from the other cell types, the secretory granules of the ghrelin cells are most similar to those of glucagon cells; however, morphometrical analysis revealed that ghrelin cells had smaller secretory granules than glucagon cells.
In 1978, Capella and coworkers described endocrine cells in the human pancreas closely resembling the previously classified gastric P-cells. Interestingly, the cells were numerous in fetal pancreas but rare in adult pancreas. Clearly, this developmental pattern greatly resembles that we reported for islet ghrelin cells in human pancreas (Wierup et al. 2002) . Further, Capella et al. (1978) reported that the secretory granules of these cells had a mean diameter of approximately 130 nm and the cells were classified as P/D1-cells (see above). There is a high degree of resemblance between these P/D1-cells and the ghrelin cells described in the present report. Together, these data suggest that the ultrastructurally defined cells with small granules (P/D1-cells) in human islets may actually be identical to ghrelin cells. The slight difference in granule diameter between the ghrelin granules in the present investigation and those described by Capella et al. (1978) could be due to different fixation used and/or because that we have measured the dense-core diameter rather than the full diameter including the granule membrane.
Moreover, the ultrastructure of the pancreatic ghrelin cells displays a high degree of resemblance to the human gastric ghrelin cells recently characterised by Rindi et al. (2002) , with the exception of the slightly larger granules in the gastric ghrelin cells compared with those in the pancreatic cells (147 nm versus 110 nm).
In conclusion this study provides evidence for a unique ultrastructure of the recently discovered islet ghrelin cells vs other hormonally identified islet cells and emphasizes the ghrelin cell as a fifth islet cell type.
